Vitalhub (TSE:VHI) PT Set at C$7.50 by Cormark

Cormark set a C$7.50 target price on Vitalhub (TSE:VHI) in a research note issued to investors on Monday morning, BayStreet.CA reports. The brokerage currently has a buy rating on the stock. Cormark also issued estimates for Vitalhub’s FY2025 earnings at $0.26 EPS.

VHI has been the topic of several other reports. Eight Capital boosted their price target on shares of Vitalhub from C$5.00 to C$6.25 and gave the stock a buy rating in a research report on Tuesday, February 6th. Canaccord Genuity Group upped their target price on shares of Vitalhub from C$5.25 to C$5.50 and gave the company a buy rating in a report on Tuesday, February 6th.

Vitalhub Trading Up 3.9 %

Shares of TSE VHI opened at C$6.60 on Monday. The firm has a market cap of C$288.49 million, a PE ratio of 66.00, a PEG ratio of 0.42 and a beta of 1.21. Vitalhub has a 1-year low of C$2.35 and a 1-year high of C$6.86. The company has a fifty day moving average price of C$6.03 and a 200 day moving average price of C$4.56.

Vitalhub (TSE:VHI) last issued its quarterly earnings results on Thursday, March 21st. The company reported C$0.03 EPS for the quarter, missing the consensus estimate of C$0.04 by C($0.01). Vitalhub had a return on equity of 5.78% and a net margin of 8.66%. The business had revenue of C$13.60 million for the quarter, compared to the consensus estimate of C$13.68 million. Equities research analysts forecast that Vitalhub will post 0.1501823 EPS for the current year.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.